I would assume that the TGA rarely approves clinical trials within Australia without passing stringent requirements, so Imugene has been able to cross the line and broaden its clinical trials outside of US
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.050(11.8%) |
Mkt cap ! $83.46M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 38.0¢ | 34.5¢ | $1.106M | 3.007M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 148280 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 22500 | 10 |
View Market Depth
| Last trade - 15.04pm 16/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |